Regenerative Medical Technology Group Inc. income statement RMTG

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Regenerative Medical Technology Group Inc. reported revenue of $5.1 million, up 24.2% from the year before. It recorded a net loss of $7.8 million. The operating loss came to $867,162, an operating margin of -17.0%. Diluted earnings per share were -$0.62. Over the twelve months ended Jun 30, 2026, revenue was $9.4 million and the net loss was $8.8 million. Across the 8 fiscal years shown, revenue grew from $50,116 in fiscal 2018 to $5.1 million in fiscal 2025, about 93.6% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018
Revenue	9 +94.3%	5 +24.2%	4 +70.4%	2 +57.5%	2 +249.5%	0 +695.0%	0 +83.0%	0 -39.9%	0
Cost of revenue	4 +138.6%	2 +78.3%	1 +74.9%	1 +12.4%	1 +127.0%	0 +554.7%	0 -20.8%	0 -18.7%	0
Gross profit	6 +72.7%	3 -0.4%	3 +68.5%	2 +91.1%	1 +484.1%	0 +1249.2%	0 +143.8%	-0 -39.5%	-0
Selling, general and administrative	2 +112.2%	1 +40.3%	1 +6.1%	1 -90.8%	8 +5389.6%	0 -28.8%	0 -0.7%	0 +390.8%	0
Operating income	0	-1 -1168.2%	0	—	—	—	—	—	—
Income tax	—	-2 -41.1%	-1 +43.6%	-2 -78.2%	-1 +57.3%	-3	—	—	—
Net income	-9 -136.7%	-8 -40.4%	-6 +43.3%	-10 -78.2%	-6 +57.3%	-13 -118.5%	-6 -135.0%	-3 -21.9%	-2
Basic EPS	-0.68 -129.4%	-0.62 -40.9%	-0.44 +44.3%	-0.79 -75.6%	-0.45 +59.8%	-1.12	—	-0.47	—
Diluted EPS	-0.68 -129.4%	-0.62 -40.9%	-0.44 +44.3%	-0.79 -75.6%	-0.45	—	—	—	—
Weighted average shares, basic	13 +3.2%	13 +0.8%	13 +0.7%	12 +1.9%	12 +6.4%	11 +22.9%	9 +76.1%	5	—
Weighted average shares, diluted	13 +3.2%	13 +0.8%	13 +0.7%	12 +1.9%	12	—	—	—	—
Other measures
Depreciation and amortization	0 +116.5%	0 +27.4%	0 -28.9%	0 +103.0%	0 +273.8%	0 +5007.2%	0 +0.0%	0 +300.0%	0
EBITDA	0	-1 -294.2%	0	—	—	—	—	—	—
Interest coverage	0.00x	-0.12x	0.01x	—	—	—	—	—	—
Margins
Gross margin	59.76%	55.11%	68.73%	69.53%	57.31%	34.29%	20.20%	-84.45%	-36.35%
Operating margin	0.46%	-17.00%	1.98%	—	—	—	—	—	—
Profit margin	-93.73%	-153.18%	-135.43%	-407.21%	-359.87%	-2,942.42%	-10,703.47%	-8,335.20%	-4,105.61%
EBITDA margin	4.32%	-11.49%	7.35%	—	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Retail-Retail Stores, NEC (SIC 5990)
Listed as: RMTG (OTC)
Fiscal year ends: December 31
Headquarters: Boca Raton, FL
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1760026
Former names: MESO NUMISMATICS, INC. (until Oct 24, 2024)

Other Retail-Retail Stores, NEC companies

JD.com, Inc. JD
Ulta Beauty, Inc. ULTA
Bath & Body Works, Inc. BBWI
Sally Beauty Holdings, Inc. SBH
ATRenew Inc. RERE
Petco Health & Wellness Company, Inc. WOOF
Titan Machinery Inc. TITN
Star Group, L.P. SGU

All 22 Retail-Retail Stores, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.